1. Home
  2. ALBT vs XBIO Comparison

ALBT vs XBIO Comparison

Compare ALBT & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avalon GloboCare Corp.

ALBT

Avalon GloboCare Corp.

HOLD

Current Price

$1.26

Market Cap

5.9M

Sector

Health Care

ML Signal

HOLD

Logo Xenetic Biosciences Inc.

XBIO

Xenetic Biosciences Inc.

HOLD

Current Price

$2.11

Market Cap

5.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALBT
XBIO
Founded
2014
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.9M
5.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ALBT
XBIO
Price
$1.26
$2.11
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
182.1K
35.9K
Earning Date
11-14-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,611,940.00
$2,858,935.00
Revenue This Year
N/A
$1.99
Revenue Next Year
N/A
$20.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
13.30
52 Week Low
$0.88
$1.90
52 Week High
$11.66
$13.93

Technical Indicators

Market Signals
Indicator
ALBT
XBIO
Relative Strength Index (RSI) 46.38 35.88
Support Level $0.88 $1.90
Resistance Level $1.40 $2.29
Average True Range (ATR) 0.19 0.16
MACD 0.03 0.02
Stochastic Oscillator 48.42 25.68

Price Performance

Historical Comparison
ALBT
XBIO

About ALBT Avalon GloboCare Corp.

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.

Share on Social Networks: